Skip to main content

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) Investor Investigation Over Possible Breaches Of Fiduciary Duties In Acquisition Announced

  • Investors who purchased shares of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) and currently hold any of those NASDAQ: PGNX shares have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

An investigation on behalf of investors, who currently hold shares of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), was announced concerning whether the takeover of Progenics Pharmaceuticals, Inc. is unfair NASDAQ: PGNX stockholders. The investigation by a law firm concerns whether certain officers and directors of Progenics Pharmaceuticals, Inc. breached their fiduciary duties owed...



You must register (for free) or login to view the entire investigation.